Tara Berman, MD, MS

Dr. Tara Berman is an oncologist at Dana-Farber Cancer Institute, specializing in treating patients with GYN malignancies, as well as a Member of Faculty at Harvard Medical School.  She also has a strong interest in integrative oncology, serving on the Board of the Society for Integrative Oncology (SIO), incorporating integrative medicine into clinical treatment plans, and focusing on integrative oncology clinical trials.  She is a recipient of the 2022 GOG New Investigator Award and was a selected participant in the SGO Bridges Research Initiative, inaugural cohort.  Prior to joining Schar, Dr. Berman helped establish the medical gynecologic oncology clinic at the Inova Schar Cancer Institute.  She was also a medical officer for the Food and Drug Administration (FDA) on the Breast/Gyn Malignancies Team in the Office of Oncologic Disease at the Center for Drug Evaluation and Research (CDER) and served as the Integrative Oncology Liaison for CDER. Dr. Berman received her medical degree from the Sackler School of Medicine in Tel Aviv and Master of Science in Nutrition from Columbia University.  She completed her internal medicine residency at Mount Sinai West in New York City and completed her Oncology Fellowship at the National Cancer Institute, National Institute of Health (NIH) in Bethesda, MD.